Spatial Omics Market to Surpass US$ 547 Mn by 2030 - Coherent Market Insights

Global Spatial Omics Market, by Technology Type (Spatial Proteomics, Spatial Transcriptomics, Spatial Genomics), by Product Type (Instruments, Consumables, Software), by Work Flow (Sample Preparation, Instrumental Analysis, Data Analysis), by Sample Type (FFPE, Fresh Frozen), by End Use (Academics & Translational Research Institutes, Pharmaceutical & Biotechnology Companies) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$  267 million in 2022 and is expected to exhibit a CAGR of 9.4 % over the forecast period (2022-2030), as highlighted in a new report published by Coherent Market Insights.

Key players operating in the market are focusing on receiving product approvals from regulatory authorities and this is expected to drive the market growth over the forecast period.

For Instance, in March 2021, Rebus Biosystems, Inc. a life science technology company creating revolutionary tools to enable spatial omics research, has launched Rebus Esper spatial platform. The new spatial omics platform will allow researchers to better understand the biology of tissues and lead to advancements in neuroscience, cancer, infectious disease and immunology.

Moreover, in October 2021, Nanostring Technologies, Inc, a leading provider of life science tools for discovery and translational research, has launched the spatial organ atlas, an annotated reference dataset of spatially resolved whole transcriptomics, providing a foundational knowledge base for researchers to quickly discover how organs function in both healthy and disease states, using the GeoMx digital spatial profiler (DSP).

Global Spatial Omics Market – Impact of Coronavirus (Covid-19) Pandemic

Coronavirus (COVID-19) outbreak was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared COVID-19, as pandemic on March 11, 2020. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 193,657,725 cases and 4,154,660 deaths due to coronavirus disease (COVID-19) were reported till July 25, 2021, across the globe.

Covid-19 had a short term impact on spatial omics market in the inception of the pandemic due to lockdown, however the impact didn’t last longer, the market of spatial omics is growing gradually with increasing sale of spatial omics solutions.

For instance, NanoString Technologies, Inc. a leading provider of life science tools for delivery and translational research had a decline in consumables revenue i.e. $ 8.4 million, 42% year-over-year decline. However, the revenue of NanoString Technologies in consumable segment increased to $ 16 million, a 39% year-over-year growth.

Browse 53 Market Data Tables and 38 Figures spread through 154 Pages and in-depth TOC on “Spatial Omics Market”- Global Forecast to 2030, by Technology Type (Spatial Proteomics, Spatial Transcriptomics, Spatial Genomics), by Product Type (Instruments, Consumables, Software), by Work Flow (Sample Preparation, Instrumental Analysis, Data Analysis), by Sample Type (FFPE, Fresh Frozen), by End Use ( Academics & Translational Research Institutes, Pharmaceutical & Biotechnology Companies) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa),

To know the latest trends and insights prevalent in the global spatial omics market, click the link below:

https://www.coherentmarketinsights.com/market-insight/spatial-omics-market-5186

Key players operating in the market are focusing on adoption of inorganic growth strategies such as mergers, collaborations, partnerships, and acquisitions, in order to strengthen their position in the global market. For instance, in December 2021, Mission Bio, a pioneer in high throughput single cell DNA and multi-omics analysis, has signed an agreement with SeqMed, a pioneer in single-cell omics technology innovation and application in china. The agreement will allow mission bio to expand its product and services offerings into china.

Key Takeaways of the Global Spatial Omics Market:

• The global spatial omics market is expected to exhibit a CAGR of 9.4% over the forecast period, owing to rising launches of products. For instance, in June 2021, bioSyntagma, Inc. unveiled the world’s first high plex multi omic spatial workflow designed for clinical samples and diagnostic applications. Compatible with FFPE and large resection up to an inch in size, the Molecular Fingerprint (mPrint) technology has been demonstrated to map tumor microenvironment with custom PCR panel, targeted and total sequencing, and spatial imaging at resolutions ranging from single cell to complex region of interest.
• Among technology type, spatial transcriptomics segment is expected to account for largest market share during the forecast period, owing to rising research and development and product launches.
• Key players operating in the global spatial omics market include 10x Genomics, Akoya Bioscience Inc., Biognosys AG, BioSpyder Technologies, Bio-Techne, Bruker, Brooks Automation Inc., Danaher Corporation, Diagenode Diagnostics, Fluidigm Corporation, IonPath Inc., Millennium Science Pty Ltd, NanoString Technologies, PerkinElmer, Rebus Biosystems, Ultivue Inc., Vizgen Corp, Dovetail Genomics, S2 Genomics, Inc., Seven Bridges Genomics.